Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles (2023 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Amortizatization of Intangibles came in at $285184.0 in Q1 2026, little changed year-on-year from $285184.0 in Q1 2025, and little changed quarter-over-quarter from $285185.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $285184.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $285184.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (changed 0.0% YoY), and the FY2025 annual result was $1.1 million, changed 0.0% from the prior year.
- Amortizatization of Intangibles came in at $285184.0 for Q1 2026 at Cumberland Pharmaceuticals, roughly flat from $285185.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $296150.0 in Q2 2023 to a low of $125479.0 in Q4 2023.
- The 4-year median for Amortizatization of Intangibles is $285184.0 (2024), against an average of $261627.7.
- Peak annual rise in Amortizatization of Intangibles reached 127.28% in 2024, while the deepest fall reached 3.7% in 2024.
- Cumberland Pharmaceuticals' Amortizatization of Intangibles stood at $125479.0 in 2023, then surged by 127.28% to $285185.0 in 2024, then changed by 0.0% to $285185.0 in 2025, then decreased by 0.0% to $285184.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $285184.0 (Q1 2026), $285185.0 (Q4 2025), and $285184.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Cumberland Pharmaceuticals | 81.83 Mn | 70.49 Mn | 7.20 Mn | 285,184.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,184.00 |
| Mar 31, 2026 | 285,184.00 |
| Dec 31, 2025 | 285,185.00 |
| Dec 31, 2025 | 285,185.00 |
| Sep 30, 2025 | 285,184.00 |
| Sep 30, 2025 | 285,184.00 |
| Jun 30, 2025 | 285,185.00 |
| Jun 30, 2025 | 285,185.00 |
| Mar 31, 2025 | 285,184.00 |
| Mar 31, 2025 | 285,184.00 |
| Dec 31, 2024 | 285,185.00 |
| Dec 31, 2024 | 285,185.00 |
| Sep 30, 2024 | 285,184.00 |
| Sep 30, 2024 | 285,184.00 |
| Jun 30, 2024 | 285,185.00 |
| Jun 30, 2024 | 285,185.00 |
| Mar 31, 2024 | 285,184.00 |
| Mar 31, 2024 | 285,184.00 |
| Dec 31, 2023 | 125,479.00 |
| Dec 31, 2023 | 125,479.00 |